Reviva Pharmaceuticals Holdings, Inc. (RVPH) — 10-Q Filings

10-Q Filings (6)

• Reviva Narrows Losses, Boosts Cash Amidst Ongoing Funding Needs — Nov 13, 2025 Risk: high
  REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) reported a net loss of $4.01 million for the three months ended September 30, 2025, a significant improvement from
• Reviva Narrows Losses, Raises Capital Amidst Going Concern Warning — Aug 14, 2025 Risk: high
  REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) reported a net loss of $6.05 million for the three months ended June 30, 2025, an improvement from a net loss of $7
• Reviva Pharmaceuticals Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Reviva Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and operational updates for
• Reviva Pharmaceuticals Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  Reviva Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Tenzing Acquisition Corp., is incorporated
• Reviva Pharmaceuticals Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Reviva Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial information and operational updates for t
• Reviva Pharmaceuticals Holdings, Inc. Files 10-Q for Q1 2024 — May 14, 2024 Risk: medium
  REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Reviva Pharmaceuticals Holdings, Inc. filed a 10-Q fo

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX